期刊文献+

血清CEA、SCC-Ag水平联合检测在早期子宫颈癌诊断中的应用价值 被引量:1

The Value of Combined Detection of Serum CEA and SCC-Ag Levels in the Diagnosis of Early Cervical Cancer
下载PDF
导出
摘要 目的观察血清癌胚抗原(CEA)、鳞状上皮细胞癌抗原(SCC-Ag)水平联合检测在早期子宫颈癌诊断中的应用价值。方法选取2016年8月~2018年2月本院37例早期子宫颈癌患者作为子宫颈癌组,选取同期本院37例良性子宫疾病患者作为对照组,采用酶联免疫法测定血清CEA水平,采用磁分离酶联免疫法测定血清SCC-Ag水平。结果子宫颈癌组血清CEA、SCC-Ag水平高于对照组(P <0.05);Ⅰ期/Ⅱ期子宫颈癌患者血清CEA、SCC-Ag检测阳性率低于Ⅲ期/Ⅳ期;鳞癌血清CEA检测阳性率低于腺癌,SCC-Ag检测阳性率高于腺癌(P <0.05);血清CEA、SCC-Ag联合检测敏感度、诊断准确度较血清CEA、SCC-Ag单独检测高(P <0.05)。结论血清CEA、SCCAg水平与子宫颈癌发生、发展有密切关系,其水平检测在早期子宫颈癌临床分期诊断中具有重要价值,二者联合可提高诊断敏感度与准确度,其中SCC-Ag在子宫颈鳞癌诊断中价值较高。 Objective To observe the value of combined detection of serum carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) levels in the diagnosis of early cervical cancer. Methods 37 patients with early cervical cancer in our hospita from August 2016 to February 2018 were enrolled in the cervical cancer group. 37 patients with benign uterine disease in our hospital were selected as the control group. Serum CEA levels were determined by enzyme-linked immunosorbent assay. Serum SCC-Ag levels were determined by magnetic separation enzyme-linked immunosorbent assay. Results The levels of serum CEA and SCC-Ag in cervical cancer group were higher than those in the control group (P < 0.05). The positive rate of serum CEA and SCC-Ag in stage I/II cervical cancer patients was lower than that in stage III/IV. The positive rate of serum CEA in squamous cell carcinoma was lower than that in adenocarcinoma and the positive rate of SCC-Ag was higher than that of adenocarcinoma (P < 0.05). The sensitivity of combined detection of CEA and SCC-Ag was higher than that of serum CEA and SCC-Ag alone.(P < 0.05). Conclusion The levels of serum CEA and SCC-Ag are closely related to the occurrence and development of cervical cancer. The detection of serum levels is of great value in the clinical diagnosis of early stage cervical cancer. The combination of the two can improve the sensitivity and accuracy of diagnosis. SCC-Ag is especially of high value in the diagnosis of cervical squamous cell carcinoma.
作者 郑艳冰 ZHENG Yan-bing(The First Affiliated Hospital of Nanyang Medical College, Nanyang, Henan, 473000, China)
出处 《临床研究》 2019年第7期136-138,共3页 Clinical Research
关键词 癌胚抗原 鳞状上皮细胞癌抗原 子宫颈癌 阳性检出率 carcinoembryonic antigen squamous cell carcinoma antigen cervical cancer positive detection rate
  • 相关文献

参考文献5

二级参考文献63

  • 1潘凌亚.HPV感染与宫颈癌前病变[J].基础医学与临床,2006,26(12):1296-1301. 被引量:26
  • 2蔡娱飞,刘力.人乳头瘤病毒感染与宫颈癌关系的研究进展[J].中国误诊学杂志,2007,7(1):28-30. 被引量:5
  • 3洪锡田,王景萍,张瑞丽.血清CA153、CA125、CEA、SF检测在乳腺癌诊断中的价值[J].中国民康医学,2007,19(1):23-24. 被引量:22
  • 4Bray F, Ren JS, Masuyer E, et al. Global estimates of cancer prevalence for 27 sites in the adult population in 2008[J]. Int J Cancer, 2013, 132(5):1133-1145. 被引量:1
  • 5Roneo G, Giorgi-Rossi P, Carozzi F, et al. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial[J]. Lancet Oncol, 2010, 11(3):249-257. 被引量:1
  • 6Franceschi S, Denny L, Irwin KL, et al. Eurogin 2010 roadmap on cervical cancer prevention[J]. Int J Cancer, 2011, 128(12) :2765 -2774. 被引量:1
  • 7Li N, Franceschi S, Howell-Jones R, et al. Human papillomavirus type distrlhution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication[J]. Int J Cancer, 2011,128(4):927-935. 被引量:1
  • 8Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China[J]. Lancet Oncol, 2008, 9(10):929-936. 被引量:1
  • 9Liu Q, Wang B, Kong Y, et al. China's primary health-care reform[J]. Lancet, 2011,377(9783):2064-2066. 被引量:1
  • 10Lu S, Cong X, Li M, et al. Distribution of high-risk human papillomavirus genotypes in HPV-infected women in Beijing, China[J]. J Med Virol, 2015, 87(3):504-507. 被引量:1

共引文献211

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部